申请人:[en]MYROBALAN THERAPEUTICS NANJING CO. LTD
公开号:WO2024104462A1
公开(公告)日:2024-05-23
Disclosed herein are compounds capable of modulating GPR17 and pharmaceutical compositions of such compounds and methods of treatment for conditions, e.g., neurodegenerative diseases or demyelinating diseases, using such pharmaceutical compositions.